Novanta Stock Price, News & Analysis (NASDAQ:NOVT)

0 analysts have issued twelve-month price targets for Novanta's shares. Their NOVT share price targets range from $161.00 to $161.00. On average, they predict the company's share price to reach $161.00 in the next twelve months. This suggests a possible upside of 6.8% from the stock's current price.
View analysts price targets for NOVT or view top-rated stocks among Wall Street analysts.

Novanta's stock was trading at $135.87 at the beginning of 2023. Since then, NOVT shares have increased by 10.9% and is now trading at $150.71.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 6th 2024.
View our NOVT earnings forecast.

Novanta Inc. (NASDAQ:NOVT) posted its earnings results on Tuesday, November, 7th. The technology company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.74 by $0.11. The technology company had revenue of $221.50 million for the quarter, compared to analysts' expectations of $223.18 million. Novanta had a trailing twelve-month return on equity of 18.54% and a net margin of 8.51%. The company's revenue was down .7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.81 EPS.

ETFs with the largest weight of Novanta (NASDAQ:NOVT) stock in their portfolio include Goldman Sachs Future Health Care Equity ETF (GDOC), ROBO Global Robotics & Automation ETF (ROBO), VanEck Robotics ETF (IBOT), Franklin U.S. Small Cap Multifactor Index ETF (FLQS), Nuveen ESG Small-Cap ETF (NUSC), Vanguard S&P Mid-Cap 400 Growth ETF (IVOG), iShares Russell 2000 Growth ETF (IWO) and Vanguard Russell 2000 Growth ETF (VTWG).

Novanta updated its fourth quarter earnings guidance on Tuesday, November, 7th. The company provided EPS guidance of $0.59-0.66 for the period, compared to the consensus earnings per share estimate of $0.80. The company issued revenue guidance of $208-212 million, compared to the consensus revenue estimate of $227.56 million.

44 employees have rated Novanta Chief Executive Officer Matthijs Glastra on Glassdoor.com. Matthijs Glastra has an approval rating of 87% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Novanta investors own include NVIDIA (NVDA), Alibaba Group (BABA), Gilead Sciences (GILD), Intuitive Surgical (ISRG), Lam Research (LRCX), Altria Group (MO), AT&T (T), Abiomed (ABMD), Advanced Micro Devices (AMD) and Broadcom (AVGO).

Novanta's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Conestoga Capital Advisors LLC (3.57%), William Blair Investment Management LLC (2.71%), JPMorgan Chase & Co. (2.32%), Allspring Global Investments Holdings LLC (2.15%), Invesco Ltd. (1.86%) and Artisan Partners Limited Partnership (1.85%). Insiders that own company stock include Brian S Young, Matthijs Glastra, Robert Buckley and Thomas N Secor.
View institutional ownership trends.

Shares of NOVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.